Publications
July 2018 :: PLRH Commentary
Inverting the patient involvement paradigm: defining patient led research
Mader LB, Harris T, Kläger S, Wilkinson IB, Hiemstra TF. Research Involvement and Engagement (2018) 4:21. doi.org/10.1186/s40900-018-0104-4
May 2018 :: DRINK Randomised Feasibility Trial
Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial
El-Damanawi R, Lee M, Harris T, Mader LB, Bond S, Pavey H, Sandford RN, Wilkinson IB, Burrows A, Woznowski P, Ben-Shlomo Y, Karet Frankl FE, Hiemstra TF. BMJ Open (2018) 8:e022859. doi:10.1136/ bmjopen-2018-022859
June 2017 :: DRINK Randomised Feasibility Trial
Patient survey of current water intake practices in autosomal dominant polycystic kidney disease: the SIPs survey
El-Damanawi R, Harris T, Sandford RN, Karet Frankl FE, Hiemstra TF. Clinical Kidney Journal (2017) 10:3. doi: 10.1093/ckj/sfw153